Selected research
Industry Research
Sitagliptin Intermediates Industry Research Report 2026
Market perspective
The global Sitagliptin Intermediates market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Sitagliptin Intermediates is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Sitagliptin Intermediates is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Sitagliptin Intermediates is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Sitagliptin Intermediates include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Sitagliptin Intermediates market in revenue (US$ million) and, where applicable, sales volume (K Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/K Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Sitagliptin Intermediates.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Sitagliptin Intermediates Market by Company
Yongtai Technology
Abiochem Biotechnology
Merck
Longlife Bio-Pharmaceutical
Infinity Scientific
Zymergen
Shodhana Laboratories
Phebra
Novozymes
Ginkgo Bioworks
CVR Life Sciences
Acanthus Research
Actis Generics
Amgen
Amyris
Codexis
Furui Biopharma Technology
Zhenlei Chemical
Arromax Pharmatech
Yisheng Pharmaceutical
Sitagliptin Intermediates Segment by Type
Fluorophenyl
Chloropyridine Derivatives
Trifluoromethylquinoline Derivatives
Others
Sitagliptin Intermediates Segment by Application
Original Drug
Generic Drug
Sitagliptin Intermediates Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sitagliptin Intermediates market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sitagliptin Intermediates and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sitagliptin Intermediates.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Sitagliptin Intermediates manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Sitagliptin Intermediates by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Sitagliptin Intermediates in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Sitagliptin Intermediates Production by Manufacturers (K Tons) & (2021-2026)
Table 6. Global Sitagliptin Intermediates Production Market Share by Manufacturers
Table 7. Global Sitagliptin Intermediates Production Value by Manufacturers (US$ Million) & (2021-2026)
Table 8. Global Sitagliptin Intermediates Production Value Market Share by Manufacturers (2021-2026)
Table 9. Global Sitagliptin Intermediates Average Price (US$/Ton) of Manufacturers (2021-2026)
Table 10. Global Sitagliptin Intermediates Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
Table 11. Global Sitagliptin Intermediates Key Manufacturers, Manufacturing Sites & Headquarters
Table 12. Global Sitagliptin Intermediates Manufacturers, Product Type & Application
Table 13. Global Sitagliptin Intermediates Manufacturers Established Date
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Sitagliptin Intermediates by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025)
Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 17. Yongtai Technology Company Information
Table 18. Yongtai Technology Business Overview
Table 19. Yongtai Technology Sitagliptin Intermediates Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 20. Yongtai Technology Sitagliptin Intermediates Product Portfolio
Table 21. Yongtai Technology Recent Development
Table 22. Abiochem Biotechnology Company Information
Table 23. Abiochem Biotechnology Business Overview
Table 24. Abiochem Biotechnology Sitagliptin Intermediates Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 25. Abiochem Biotechnology Sitagliptin Intermediates Product Portfolio
Table 26. Abiochem Biotechnology Recent Development
Table 27. Merck Company Information
Table 28. Merck Business Overview
Table 29. Merck Sitagliptin Intermediates Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 30. Merck Sitagliptin Intermediates Product Portfolio
Table 31. Merck Recent Development
Table 32. Longlife Bio-Pharmaceutical Company Information
Table 33. Longlife Bio-Pharmaceutical Business Overview
Table 34. Longlife Bio-Pharmaceutical Sitagliptin Intermediates Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 35. Longlife Bio-Pharmaceutical Sitagliptin Intermediates Product Portfolio
Table 36. Longlife Bio-Pharmaceutical Recent Development
Table 37. Infinity Scientific Company Information
Table 38. Infinity Scientific Business Overview
Table 39. Infinity Scientific Sitagliptin Intermediates Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 40. Infinity Scientific Sitagliptin Intermediates Product Portfolio
Table 41. Infinity Scientific Recent Development
Table 42. Zymergen Company Information
Table 43. Zymergen Business Overview
Table 44. Zymergen Sitagliptin Intermediates Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 45. Zymergen Sitagliptin Intermediates Product Portfolio
Table 46. Zymergen Recent Development
Table 47. Shodhana Laboratories Company Information
Table 48. Shodhana Laboratories Business Overview
Table 49. Shodhana Laboratories Sitagliptin Intermediates Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 50. Shodhana Laboratories Sitagliptin Intermediates Product Portfolio
Table 51. Shodhana Laboratories Recent Development
Table 52. Phebra Company Information
Table 53. Phebra Business Overview
Table 54. Phebra Sitagliptin Intermediates Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 55. Phebra Sitagliptin Intermediates Product Portfolio
Table 56. Phebra Recent Development
Table 57. Novozymes Company Information
Table 58. Novozymes Business Overview
Table 59. Novozymes Sitagliptin Intermediates Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 60. Novozymes Sitagliptin Intermediates Product Portfolio
Table 61. Novozymes Recent Development
Table 62. Ginkgo Bioworks Company Information
Table 63. Ginkgo Bioworks Business Overview
Table 64. Ginkgo Bioworks Sitagliptin Intermediates Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 65. Ginkgo Bioworks Sitagliptin Intermediates Product Portfolio
Table 66. Ginkgo Bioworks Recent Development
Table 67. CVR Life Sciences Company Information
Table 68. CVR Life Sciences Business Overview
Table 69. CVR Life Sciences Sitagliptin Intermediates Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 70. CVR Life Sciences Sitagliptin Intermediates Product Portfolio
Table 71. CVR Life Sciences Recent Development
Table 72. Acanthus Research Company Information
Table 73. Acanthus Research Business Overview
Table 74. Acanthus Research Sitagliptin Intermediates Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 75. Acanthus Research Sitagliptin Intermediates Product Portfolio
Table 76. Acanthus Research Recent Development
Table 77. Actis Generics Company Information
Table 78. Actis Generics Business Overview
Table 79. Actis Generics Sitagliptin Intermediates Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 80. Actis Generics Sitagliptin Intermediates Product Portfolio
Table 81. Actis Generics Recent Development
Table 82. Amgen Company Information
Table 83. Amgen Business Overview
Table 84. Amgen Sitagliptin Intermediates Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 85. Amgen Sitagliptin Intermediates Product Portfolio
Table 86. Amgen Recent Development
Table 87. Amyris Company Information
Table 88. Amyris Business Overview
Table 89. Amyris Sitagliptin Intermediates Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 90. Amyris Sitagliptin Intermediates Product Portfolio
Table 91. Amyris Recent Development
Table 92. Codexis Company Information
Table 93. Codexis Business Overview
Table 94. Codexis Sitagliptin Intermediates Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 95. Codexis Sitagliptin Intermediates Product Portfolio
Table 96. Codexis Recent Development
Table 97. Furui Biopharma Technology Company Information
Table 98. Furui Biopharma Technology Business Overview
Table 99. Furui Biopharma Technology Sitagliptin Intermediates Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 100. Furui Biopharma Technology Sitagliptin Intermediates Product Portfolio
Table 101. Furui Biopharma Technology Recent Development
Table 102. Zhenlei Chemical Company Information
Table 103. Zhenlei Chemical Business Overview
Table 104. Zhenlei Chemical Sitagliptin Intermediates Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 105. Zhenlei Chemical Sitagliptin Intermediates Product Portfolio
Table 106. Zhenlei Chemical Recent Development
Table 107. Arromax Pharmatech Company Information
Table 108. Arromax Pharmatech Business Overview
Table 109. Arromax Pharmatech Sitagliptin Intermediates Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 110. Arromax Pharmatech Sitagliptin Intermediates Product Portfolio
Table 111. Arromax Pharmatech Recent Development
Table 112. Yisheng Pharmaceutical Company Information
Table 113. Yisheng Pharmaceutical Business Overview
Table 114. Yisheng Pharmaceutical Sitagliptin Intermediates Production (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 115. Yisheng Pharmaceutical Sitagliptin Intermediates Product Portfolio
Table 116. Yisheng Pharmaceutical Recent Development
Table 117. Global Sitagliptin Intermediates Production Comparison by Region: 2021 VS 2025 VS 2032 (K Tons)
Table 118. Global Sitagliptin Intermediates Production by Region (2021-2026) & (K Tons)
Table 119. Global Sitagliptin Intermediates Production Market Share by Region (2021-2026)
Table 120. Global Sitagliptin Intermediates Production Forecast by Region (2027-2032) & (K Tons)
Table 121. Global Sitagliptin Intermediates Production Market Share Forecast by Region (2027-2032)
Table 122. Global Sitagliptin Intermediates Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 123. Global Sitagliptin Intermediates Production Value by Region (2021-2026) & (US$ Million)
Table 124. Global Sitagliptin Intermediates Production Value Market Share by Region (2021-2026)
Table 125. Global Sitagliptin Intermediates Production Value Forecast by Region (2027-2032) & (US$ Million)
Table 126. Global Sitagliptin Intermediates Market Average Price (US$/Ton) by Region (2021-2026)
Table 127. Global Sitagliptin Intermediates Market Average Price (US$/Ton) by Region (2027-2032)
Table 128. Global Sitagliptin Intermediates Consumption Comparison by Region: 2021 VS 2025 VS 2032 (K Tons)
Table 129. Global Sitagliptin Intermediates Consumption by Region (2021-2026) & (K Tons)
Table 130. Global Sitagliptin Intermediates Consumption Market Share by Region (2021-2026)
Table 131. Global Sitagliptin Intermediates Forecasted Consumption by Region (2027-2032) & (K Tons)
Table 132. Global Sitagliptin Intermediates Forecasted Consumption Market Share by Region (2027-2032)
Table 133. North America Sitagliptin Intermediates Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons)
Table 134. North America Sitagliptin Intermediates Consumption by Country (2021-2026) & (K Tons)
Table 135. North America Sitagliptin Intermediates Consumption by Country (2027-2032) & (K Tons)
Table 136. Europe Sitagliptin Intermediates Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons)
Table 137. Europe Sitagliptin Intermediates Consumption by Country (2021-2026) & (K Tons)
Table 138. Europe Sitagliptin Intermediates Consumption by Country (2027-2032) & (K Tons)
Table 139. Asia Pacific Sitagliptin Intermediates Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons)
Table 140. Asia Pacific Sitagliptin Intermediates Consumption by Country (2021-2026) & (K Tons)
Table 141. Asia Pacific Sitagliptin Intermediates Consumption by Country (2027-2032) & (K Tons)
Table 142. South America, Middle East & Africa Sitagliptin Intermediates Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons)
Table 143. South America, Middle East & Africa Sitagliptin Intermediates Consumption by Country (2021-2026) & (K Tons)
Table 144. South America, Middle East & Africa Sitagliptin Intermediates Consumption by Country (2027-2032) & (K Tons)
Table 145. Global Sitagliptin Intermediates Production by Type (2021-2026) & (K Tons)
Table 146. Global Sitagliptin Intermediates Production by Type (2027-2032) & (K Tons)
Table 147. Global Sitagliptin Intermediates Production Market Share by Type (2021-2026)
Table 148. Global Sitagliptin Intermediates Production Market Share by Type (2027-2032)
Table 149. Global Sitagliptin Intermediates Production Value by Type (2021-2026) & (US$ Million)
Table 150. Global Sitagliptin Intermediates Production Value by Type (2027-2032) & (US$ Million)
Table 151. Global Sitagliptin Intermediates Production Value Market Share by Type (2021-2026)
Table 152. Global Sitagliptin Intermediates Production Value Market Share by Type (2027-2032)
Table 153. Global Sitagliptin Intermediates Price by Type (2021-2026) & (US$/Ton)
Table 154. Global Sitagliptin Intermediates Price by Type (2027-2032) & (US$/Ton)
Table 155. Global Sitagliptin Intermediates Production by Application (2021-2026) & (K Tons)
Table 156. Global Sitagliptin Intermediates Production by Application (2027-2032) & (K Tons)
Table 157. Global Sitagliptin Intermediates Production Market Share by Application (2021-2026)
Table 158. Global Sitagliptin Intermediates Production Market Share by Application (2027-2032)
Table 159. Global Sitagliptin Intermediates Production Value by Application (2021-2026) & (US$ Million)
Table 160. Global Sitagliptin Intermediates Production Value by Application (2027-2032) & (US$ Million)
Table 161. Global Sitagliptin Intermediates Production Value Market Share by Application (2021-2026)
Table 162. Global Sitagliptin Intermediates Production Value Market Share by Application (2027-2032)
Table 163. Global Sitagliptin Intermediates Price by Application (2021-2026) & (US$/Ton)
Table 164. Global Sitagliptin Intermediates Price by Application (2027-2032) & (US$/Ton)
Table 165. Key Raw Materials
Table 166. Raw Materials Key Suppliers
Table 167. Sitagliptin Intermediates Distributors List
Table 168. Sitagliptin Intermediates Customers List
Table 169. Sitagliptin Intermediates Industry Trends
Table 170. Sitagliptin Intermediates Industry Drivers
Table 171. Sitagliptin Intermediates Industry Restraints
Table 172. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Sitagliptin Intermediates Product Image
Figure 5. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 6. Fluorophenyl Product Image
Figure 7. Chloropyridine Derivatives Product Image
Figure 8. Trifluoromethylquinoline Derivatives Product Image
Figure 9. Others Product Image
Figure 10. Original Drug Product Image
Figure 11. Generic Drug Product Image
Figure 12. Global Sitagliptin Intermediates Production Value (US$ Million), 2021 VS 2025 VS 2032
Figure 13. Global Sitagliptin Intermediates Production Value (2021-2032) & (US$ Million)
Figure 14. Global Sitagliptin Intermediates Production Capacity (2021-2032) & (K Tons)
Figure 15. Global Sitagliptin Intermediates Production (2021-2032) & (K Tons)
Figure 16. Global Sitagliptin Intermediates Average Price (US$/Ton) & (2021-2032)
Figure 17. Global Sitagliptin Intermediates Key Manufacturers, Manufacturing Sites & Headquarters
Figure 18. Global Top 5 and 10 Sitagliptin Intermediates Players Market Share by Production Value in 2025
Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 20. Global Sitagliptin Intermediates Production Comparison by Region: 2021 VS 2025 VS 2032 (K Tons)
Figure 21. Global Sitagliptin Intermediates Production Market Share by Region: 2021 VS 2025 VS 2032
Figure 22. Global Sitagliptin Intermediates Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 23. Global Sitagliptin Intermediates Production Value Market Share by Region: 2021 VS 2025 VS 2032
Figure 24. North America Sitagliptin Intermediates Production Value (US$ Million) Growth Rate (2021-2032)
Figure 25. Europe Sitagliptin Intermediates Production Value (US$ Million) Growth Rate (2021-2032)
Figure 26. China Sitagliptin Intermediates Production Value (US$ Million) Growth Rate (2021-2032)
Figure 27. Japan Sitagliptin Intermediates Production Value (US$ Million) Growth Rate (2021-2032)
Figure 28. Global Sitagliptin Intermediates Consumption Comparison by Region: 2021 VS 2025 VS 2032 (K Tons)
Figure 29. Global Sitagliptin Intermediates Consumption Market Share by Region: 2021 VS 2025 VS 2032
Figure 30. North America Sitagliptin Intermediates Consumption and Growth Rate (2021-2032) & (K Tons)
Figure 31. North America Sitagliptin Intermediates Consumption Market Share by Country (2021-2032)
Figure 32. United States Sitagliptin Intermediates Consumption and Growth Rate (2021-2032) & (K Tons)
Figure 33. United States Sitagliptin Intermediates Consumption and Growth Rate (2021-2032) & (K Tons)
Figure 34. Canada Sitagliptin Intermediates Consumption and Growth Rate (2021-2032) & (K Tons)
Figure 35. Europe Sitagliptin Intermediates Consumption and Growth Rate (2021-2032) & (K Tons)
Figure 36. Europe Sitagliptin Intermediates Consumption Market Share by Country (2021-2032)
Figure 37. Germany Sitagliptin Intermediates Consumption and Growth Rate (2021-2032) & (K Tons)
Figure 38. France Sitagliptin Intermediates Consumption and Growth Rate (2021-2032) & (K Tons)
Figure 39. U.K. Sitagliptin Intermediates Consumption and Growth Rate (2021-2032) & (K Tons)
Figure 40. Italy Sitagliptin Intermediates Consumption and Growth Rate (2021-2032) & (K Tons)
Figure 41. Netherlands Sitagliptin Intermediates Consumption and Growth Rate (2021-2032) & (K Tons)
Figure 42. Asia Pacific Sitagliptin Intermediates Consumption and Growth Rate (2021-2032) & (K Tons)
Figure 43. Asia Pacific Sitagliptin Intermediates Consumption Market Share by Country (2021-2032)
Figure 44. China Sitagliptin Intermediates Consumption and Growth Rate (2021-2032) & (K Tons)
Figure 45. Japan Sitagliptin Intermediates Consumption and Growth Rate (2021-2032) & (K Tons)
Figure 46. South Korea Sitagliptin Intermediates Consumption and Growth Rate (2021-2032) & (K Tons)
Figure 47. India Sitagliptin Intermediates Consumption and Growth Rate (2021-2032) & (K Tons)
Figure 48. Australia Sitagliptin Intermediates Consumption and Growth Rate (2021-2032) & (K Tons)
Figure 49. China Taiwan Sitagliptin Intermediates Consumption and Growth Rate (2021-2032) & (K Tons)
Figure 50. Southeast Asia Sitagliptin Intermediates Consumption and Growth Rate (2021-2032) & (K Tons)
Figure 51. South America, Middle East & Africa Sitagliptin Intermediates Consumption and Growth Rate (2021-2032) & (K Tons)
Figure 52. South America, Middle East & Africa Sitagliptin Intermediates Consumption Market Share by Country (2021-2032)
Figure 53. Brazil Sitagliptin Intermediates Consumption and Growth Rate (2021-2032) & (K Tons)
Figure 54. Argentina Sitagliptin Intermediates Consumption and Growth Rate (2021-2032) & (K Tons)
Figure 55. Chile Sitagliptin Intermediates Consumption and Growth Rate (2021-2032) & (K Tons)
Figure 56. Turkey Sitagliptin Intermediates Consumption and Growth Rate (2021-2032) & (K Tons)
Figure 57. GCC Countries Sitagliptin Intermediates Consumption and Growth Rate (2021-2032) & (K Tons)
Figure 58. Global Sitagliptin Intermediates Production Market Share by Type (2021-2032)
Figure 59. Global Sitagliptin Intermediates Production Value Market Share by Type (2021-2032)
Figure 60. Global Sitagliptin Intermediates Price (US$/Ton) by Type (2021-2032)
Figure 61. Global Sitagliptin Intermediates Production Market Share by Application (2021-2032)
Figure 62. Global Sitagliptin Intermediates Production Value Market Share by Application (2021-2032)
Figure 63. Global Sitagliptin Intermediates Price (US$/Ton) by Application (2021-2032)
Figure 64. Sitagliptin Intermediates Value Chain
Figure 65. Sitagliptin Intermediates Production Mode & Process
Figure 66. Direct Comparison with Distribution Share
Figure 67. Distributors Profiles
Figure 68. Sitagliptin Intermediates Industry Opportunities and Challenges
Scope & coverage.
Types
- Fluorophenyl
- Chloropyridine Derivatives
- Trifluoromethylquinoline Derivatives
- Others
Applications
- Original Drug
- Generic Drug
Companies covered
- Yongtai Technology
- Abiochem Biotechnology
- Merck
- Longlife Bio-Pharmaceutical
- Infinity Scientific
- Zymergen
- Shodhana Laboratories
- Phebra
- Novozymes
- Ginkgo Bioworks
- CVR Life Sciences
- Acanthus Research
- Actis Generics
- Amgen
- Amyris
- Codexis
- Furui Biopharma Technology
- Zhenlei Chemical
- Arromax Pharmatech
- Yisheng Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Sitagliptin Intermediates by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Fluorophenyl
- 2.2.3 Chloropyridine Derivatives
- 2.2.4 Trifluoromethylquinoline Derivatives
- 2.2.5 Others
- 2.3 Sitagliptin Intermediates by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Original Drug
- 2.3.3 Generic Drug
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Sitagliptin Intermediates Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Sitagliptin Intermediates Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Sitagliptin Intermediates Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Sitagliptin Intermediates Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Sitagliptin Intermediates Production by Manufacturers (2021-2026)
- 3.2 Global Sitagliptin Intermediates Production Value by Manufacturers (2021-2026)
- 3.3 Global Sitagliptin Intermediates Average Price by Manufacturers (2021-2026)
- 3.4 Global Sitagliptin Intermediates Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Sitagliptin Intermediates Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Sitagliptin Intermediates Manufacturers, Product Type & Application
- 3.7 Global Sitagliptin Intermediates Manufacturers Established Date
- 3.8 Global Sitagliptin Intermediates Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Yongtai Technology
- 4.1.1 Yongtai Technology Sitagliptin Intermediates Company Information
- 4.1.2 Yongtai Technology Sitagliptin Intermediates Business Overview
- 4.1.3 Yongtai Technology Sitagliptin Intermediates Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Yongtai Technology Product Portfolio
- 4.1.5 Yongtai Technology Recent Developments
- 4.2 Abiochem Biotechnology
- 4.2.1 Abiochem Biotechnology Sitagliptin Intermediates Company Information
- 4.2.2 Abiochem Biotechnology Sitagliptin Intermediates Business Overview
- 4.2.3 Abiochem Biotechnology Sitagliptin Intermediates Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Abiochem Biotechnology Product Portfolio
- 4.2.5 Abiochem Biotechnology Recent Developments
- 4.3 Merck
- 4.3.1 Merck Sitagliptin Intermediates Company Information
- 4.3.2 Merck Sitagliptin Intermediates Business Overview
- 4.3.3 Merck Sitagliptin Intermediates Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Merck Product Portfolio
- 4.3.5 Merck Recent Developments
- 4.4 Longlife Bio-Pharmaceutical
- 4.4.1 Longlife Bio-Pharmaceutical Sitagliptin Intermediates Company Information
- 4.4.2 Longlife Bio-Pharmaceutical Sitagliptin Intermediates Business Overview
- 4.4.3 Longlife Bio-Pharmaceutical Sitagliptin Intermediates Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Longlife Bio-Pharmaceutical Product Portfolio
- 4.4.5 Longlife Bio-Pharmaceutical Recent Developments
- 4.5 Infinity Scientific
- 4.5.1 Infinity Scientific Sitagliptin Intermediates Company Information
- 4.5.2 Infinity Scientific Sitagliptin Intermediates Business Overview
- 4.5.3 Infinity Scientific Sitagliptin Intermediates Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Infinity Scientific Product Portfolio
- 4.5.5 Infinity Scientific Recent Developments
- 4.6 Zymergen
- 4.6.1 Zymergen Sitagliptin Intermediates Company Information
- 4.6.2 Zymergen Sitagliptin Intermediates Business Overview
- 4.6.3 Zymergen Sitagliptin Intermediates Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Zymergen Product Portfolio
- 4.6.5 Zymergen Recent Developments
- 4.7 Shodhana Laboratories
- 4.7.1 Shodhana Laboratories Sitagliptin Intermediates Company Information
- 4.7.2 Shodhana Laboratories Sitagliptin Intermediates Business Overview
- 4.7.3 Shodhana Laboratories Sitagliptin Intermediates Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Shodhana Laboratories Product Portfolio
- 4.7.5 Shodhana Laboratories Recent Developments
- 4.8 Phebra
- 4.8.1 Phebra Sitagliptin Intermediates Company Information
- 4.8.2 Phebra Sitagliptin Intermediates Business Overview
- 4.8.3 Phebra Sitagliptin Intermediates Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Phebra Product Portfolio
- 4.8.5 Phebra Recent Developments
- 4.9 Novozymes
- 4.9.1 Novozymes Sitagliptin Intermediates Company Information
- 4.9.2 Novozymes Sitagliptin Intermediates Business Overview
- 4.9.3 Novozymes Sitagliptin Intermediates Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 Novozymes Product Portfolio
- 4.9.5 Novozymes Recent Developments
- 4.10 Ginkgo Bioworks
- 4.10.1 Ginkgo Bioworks Sitagliptin Intermediates Company Information
- 4.10.2 Ginkgo Bioworks Sitagliptin Intermediates Business Overview
- 4.10.3 Ginkgo Bioworks Sitagliptin Intermediates Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 Ginkgo Bioworks Product Portfolio
- 4.10.5 Ginkgo Bioworks Recent Developments
- 4.11 CVR Life Sciences
- 4.11.1 CVR Life Sciences Sitagliptin Intermediates Company Information
- 4.11.2 CVR Life Sciences Sitagliptin Intermediates Business Overview
- 4.11.3 CVR Life Sciences Sitagliptin Intermediates Production Capacity, Value and Gross Margin (2021-2026)
- 4.11.4 CVR Life Sciences Product Portfolio
- 4.11.5 CVR Life Sciences Recent Developments
- 4.12 Acanthus Research
- 4.12.1 Acanthus Research Sitagliptin Intermediates Company Information
- 4.12.2 Acanthus Research Sitagliptin Intermediates Business Overview
- 4.12.3 Acanthus Research Sitagliptin Intermediates Production Capacity, Value and Gross Margin (2021-2026)
- 4.12.4 Acanthus Research Product Portfolio
- 4.12.5 Acanthus Research Recent Developments
- 4.13 Actis Generics
- 4.13.1 Actis Generics Sitagliptin Intermediates Company Information
- 4.13.2 Actis Generics Sitagliptin Intermediates Business Overview
- 4.13.3 Actis Generics Sitagliptin Intermediates Production Capacity, Value and Gross Margin (2021-2026)
- 4.13.4 Actis Generics Product Portfolio
- 4.13.5 Actis Generics Recent Developments
- 4.14 Amgen
- 4.14.1 Amgen Sitagliptin Intermediates Company Information
- 4.14.2 Amgen Sitagliptin Intermediates Business Overview
- 4.14.3 Amgen Sitagliptin Intermediates Production Capacity, Value and Gross Margin (2021-2026)
- 4.14.4 Amgen Product Portfolio
- 4.14.5 Amgen Recent Developments
- 4.15 Amyris
- 4.15.1 Amyris Sitagliptin Intermediates Company Information
- 4.15.2 Amyris Sitagliptin Intermediates Business Overview
- 4.15.3 Amyris Sitagliptin Intermediates Production Capacity, Value and Gross Margin (2021-2026)
- 4.15.4 Amyris Product Portfolio
- 4.15.5 Amyris Recent Developments
- 4.16 Codexis
- 4.16.1 Codexis Sitagliptin Intermediates Company Information
- 4.16.2 Codexis Sitagliptin Intermediates Business Overview
- 4.16.3 Codexis Sitagliptin Intermediates Production Capacity, Value and Gross Margin (2021-2026)
- 4.16.4 Codexis Product Portfolio
- 4.16.5 Codexis Recent Developments
- 4.17 Furui Biopharma Technology
- 4.17.1 Furui Biopharma Technology Sitagliptin Intermediates Company Information
- 4.17.2 Furui Biopharma Technology Sitagliptin Intermediates Business Overview
- 4.17.3 Furui Biopharma Technology Sitagliptin Intermediates Production Capacity, Value and Gross Margin (2021-2026)
- 4.17.4 Furui Biopharma Technology Product Portfolio
- 4.17.5 Furui Biopharma Technology Recent Developments
- 4.18 Zhenlei Chemical
- 4.18.1 Zhenlei Chemical Sitagliptin Intermediates Company Information
- 4.18.2 Zhenlei Chemical Sitagliptin Intermediates Business Overview
- 4.18.3 Zhenlei Chemical Sitagliptin Intermediates Production Capacity, Value and Gross Margin (2021-2026)
- 4.18.4 Zhenlei Chemical Product Portfolio
- 4.18.5 Zhenlei Chemical Recent Developments
- 4.19 Arromax Pharmatech
- 4.19.1 Arromax Pharmatech Sitagliptin Intermediates Company Information
- 4.19.2 Arromax Pharmatech Sitagliptin Intermediates Business Overview
- 4.19.3 Arromax Pharmatech Sitagliptin Intermediates Production Capacity, Value and Gross Margin (2021-2026)
- 4.19.4 Arromax Pharmatech Product Portfolio
- 4.19.5 Arromax Pharmatech Recent Developments
- 4.20 Yisheng Pharmaceutical
- 4.20.1 Yisheng Pharmaceutical Sitagliptin Intermediates Company Information
- 4.20.2 Yisheng Pharmaceutical Sitagliptin Intermediates Business Overview
- 4.20.3 Yisheng Pharmaceutical Sitagliptin Intermediates Production Capacity, Value and Gross Margin (2021-2026)
- 4.20.4 Yisheng Pharmaceutical Product Portfolio
- 4.20.5 Yisheng Pharmaceutical Recent Developments
5 Global Sitagliptin Intermediates Production by Region
- 5.1 Global Sitagliptin Intermediates Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Sitagliptin Intermediates Production by Region: 2021-2032
- 5.2.1 Global Sitagliptin Intermediates Production by Region: 2021-2026
- 5.2.2 Global Sitagliptin Intermediates Production Forecast by Region (2027-2032)
- 5.3 Global Sitagliptin Intermediates Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Sitagliptin Intermediates Production Value by Region: 2021-2032
- 5.4.1 Global Sitagliptin Intermediates Production Value by Region: 2021-2026
- 5.4.2 Global Sitagliptin Intermediates Production Value Forecast by Region (2027-2032)
- 5.5 Global Sitagliptin Intermediates Market Price Analysis by Region (2021-2026)
- 5.6 Global Sitagliptin Intermediates Production and Value, YOY Growth
- 5.6.1 North America Sitagliptin Intermediates Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Sitagliptin Intermediates Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Sitagliptin Intermediates Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Sitagliptin Intermediates Production Value Estimates and Forecasts (2021-2032)
6 Global Sitagliptin Intermediates Consumption by Region
- 6.1 Global Sitagliptin Intermediates Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Sitagliptin Intermediates Consumption by Region (2021-2032)
- 6.2.1 Global Sitagliptin Intermediates Consumption by Region: 2021-2026
- 6.2.2 Global Sitagliptin Intermediates Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Sitagliptin Intermediates Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Sitagliptin Intermediates Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.4 Europe
- 6.4.1 Europe Sitagliptin Intermediates Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Sitagliptin Intermediates Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Sitagliptin Intermediates Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Sitagliptin Intermediates Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 China Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Sitagliptin Intermediates Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Sitagliptin Intermediates Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Sitagliptin Intermediates Production by Type (2021-2032)
- 7.1.1 Global Sitagliptin Intermediates Production by Type (2021-2032) & (K Tons)
- 7.1.2 Global Sitagliptin Intermediates Production Market Share by Type (2021-2032)
- 7.2 Global Sitagliptin Intermediates Production Value by Type (2021-2032)
- 7.2.1 Global Sitagliptin Intermediates Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Sitagliptin Intermediates Production Value Market Share by Type (2021-2032)
- 7.3 Global Sitagliptin Intermediates Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Sitagliptin Intermediates Production by Application (2021-2032)
- 8.1.1 Global Sitagliptin Intermediates Production by Application (2021-2032) & (K Tons)
- 8.1.2 Global Sitagliptin Intermediates Production Market Share by Application (2021-2032)
- 8.2 Global Sitagliptin Intermediates Production Value by Application (2021-2032)
- 8.2.1 Global Sitagliptin Intermediates Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Sitagliptin Intermediates Production Value Market Share by Application (2021-2032)
- 8.3 Global Sitagliptin Intermediates Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Sitagliptin Intermediates Value Chain Analysis
- 9.1.1 Sitagliptin Intermediates Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Sitagliptin Intermediates Production Mode & Process
- 9.2 Sitagliptin Intermediates Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Sitagliptin Intermediates Distributors
- 9.2.3 Sitagliptin Intermediates Customers
10 Global Sitagliptin Intermediates Analyzing Market Dynamics
- 10.1 Sitagliptin Intermediates Industry Trends
- 10.2 Sitagliptin Intermediates Industry Drivers
- 10.3 Sitagliptin Intermediates Industry Opportunities and Challenges
- 10.4 Sitagliptin Intermediates Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$2,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst